| Literature DB >> 34352885 |
Glenn A Gaesser1, Julie Miller Jones2, Siddhartha S Angadi3.
Abstract
High-glycemic index (high-GI) foods (so-called fast carbs) have been hypothesized to promote fat storage and increase risk of obesity. To clarify whether dietary GI impacts body weight, we searched PubMed and the Cochrane Database of Systematic Reviews for observational studies reporting associations between BMI and dietary GI, and for meta-analyses of randomized controlled trials (RCTs) comparing low-GI and high-GI diets for weight loss. Data on 43 cohorts from 34 publications, totaling 1,940,968 adults, revealed no consistent differences in BMI when comparing the highest with the lowest dietary GI groups. In the 27 cohort studies that reported results of statistical comparisons, 70% showed that BMI was either not different between the highest and lowest dietary GI groups (12 of 27 cohorts) or that BMI was lower in the highest dietary GI group (7 of 27 cohorts). Results of 30 meta-analyses of RCTs from 8 publications demonstrated that low-GI diets were generally no better than high-GI diets for reducing body weight or body fat. One notable exception is that low-GI diets with a dietary GI at least 20 units lower than the comparison diet resulted in greater weight loss in adults with normal glucose tolerance but not in adults with impaired glucose tolerance. While carbohydrate quality, including GI, impacts many health outcomes, GI as a measure of carbohydrate quality appears to be relatively unimportant as a determinant of BMI or diet-induced weight loss. Based on results from observational cohort studies and meta-analyses of RCTs, we conclude that there is scant scientific evidence that low-GI diets are superior to high-GI diets for weight loss and obesity prevention.Entities:
Keywords: body mass index; carbohydrate quality; diet; glycemic index; obesity; weight loss
Mesh:
Substances:
Year: 2021 PMID: 34352885 PMCID: PMC8634321 DOI: 10.1093/advances/nmab093
Source DB: PubMed Journal: Adv Nutr ISSN: 2161-8313 Impact factor: 8.701
FIGURE 1BMI of the lowest and highest categories of dietary GI in cohort studies in which statistical analysis of BMI differences across dietary GI categories was performed. Values are means ± SDs, except in the cohorts of Spanish women and men (±95% CI). Three cohort studies did not report SDs or CIs. NS = P > 0.05. L>H = BMI in the lowest GI group was significantly greater than in the highest GI group. L
FIGURE 2BMI of the lowest and highest categories of dietary GI in cohort studies in which no statistical analysis of BMI differences across dietary GI categories was reported. Values are means ± SDs. Five cohort studies did not report SDs. NHS I, n = 74,248 (29); NHS II, n = 90,411 (29); Takahama women (n = 14,445) and men (n = 11,856) (52); Sister Study, n = 866 (44); EPIC women, n = 334,849 (40); SMC, n = 61,433 (37); HPFS, n = 40,498 (29); Zutphen, n = 394 (56); EPIC-Nutr, n = 338,325 (41); CPS-II NC, n = 30,996 (34); ARIC (Whites, n = 11,478; Blacks, n = 4211) (42); NIH-AARP, n = 482,362 (35); DiOGenes, n = 89,432 (32); MCCS, n = 36,787 (58). ARIC, Atherosclerosis Risk in Communities Study; CPS-II NC, Cancer Prevention Study II Nutrition Cohort; DiOGenes, Diet, Obesity, and Genes cohort study; EPIC/EPIC-Nutr, European Prospective Investigation into Cancer and Nutrition; GI, glycemic index; HPFS, Health Professionals Follow-Up Study; MCCS, Melbourne Collaborative Cohort Study; NHS, Nurses’ Health Study; NIH-AARP, NIH-AARP Diet and Health Study; SMC, Swedish Mammography Cohort; Zutphen, Zutphen Elderly Study.
Effects of low-GI diets compared with high-GI diets on body weight, body fat, fat-free mass, and waist circumference: results from meta-analyses of RCTs[1]
| Meta-analysis | Subject characteristics | Number of RCTs included | Difference between low-GI and high-GI diets (kg or SMD) (95% CI) |
|---|---|---|---|
| Body weight (kg) | |||
| Kelly et al., 2004 ( | At risk for CVD | 13 | 0.14 (−0.68, 0.95) kg |
| Thomas et al., 2007 ( | Overweight, obese | 4 | −1.09 (−1.99, −0.18) kg |
| Ajala et al., 2013 ( | T2D | 3 | 1.39 (−1.58, 4.36) kg |
| Schwingshackl et al., 2013 ( | Overweight, obese, T2D | 14 | −0.62 (−1.28, 0.03) kg |
| Schwingshackl et al., 2013 ( | Obese, T2D | 9 | −1.26 (−2.17, −0.34) kg |
| Schwingshackl et al., 2013 ( | Overweight, T2D | 6 | 0.04 (−0.90, 0.98) kg |
| Clar et al., 2017 ( | At risk for CVD | 20 | −0.16 (−0.54, 0.21) kg |
| Reynolds et al., 2019 ( | Overweight, obese, IGT, T2D | 8 | −0.29 (−0.62, 0.03) kg |
| Zafar et al., 2019 ( | NGT, IGT, T2D | 51 | −0.06 (−0.15, 0.03) SMD |
| Zafar et al., 2019 ( | NGT, IGT, T2D; GI difference ≥20 units | 28 | −0.14 (−0.25, −0.03) SMD |
| Zafar et al., 2019 ( | NGT; GI difference ≥20 units | 13 | −0.26 (−0.43, −0.09) SMD |
| Zafar et al., 2019 ( | IGT; GI difference ≥20 units | 8 | −0.07 (−0.28, 0.14) SMD |
| Zafar et al., 2019 ( | T2D; GI difference ≥20 units | 7 | −0.02 (−0.22, 0.18) SMD |
| Zafar et al., 2019 ( | IGT, T1D, T2D | 22 | 0.00 (−1.92, 1.92) kg |
| Zafar et al., 2019 ( | IGT, T1D, T2D; GI difference ≥20 units | 12 | −0.64 (−3.33, 2.05) kg |
| Body fat (kg) | |||
| Thomas et al., 2007 ( | Overweight, obese | 4 | −1.13 (−1.89, −0.38) kg |
| Schwingshackl et al., 2013 ( | Overweight, obese | 5 | −0.56 (−1.24, 0.12) kg |
| Reynolds et al., 2019 ( | Overweight, obese, IGT, T2D | 5 | −0.27 (−0.79, 0.26) kg |
| Zafar et al., 2019 ( | NGT, IGT, T2D | 24 | −0.09 (−0.19, 0.02) SMD |
| Zafar et al., 2019 ( | NGT | 17 | −0.10 (−0.21, 0.01) SMD |
| Zafar et al., 2019 ( | IGT | 5 | −0.06 (−0.38, 0.26) SMD |
| Zafar et al., 2019 ( | NGT, IGT, T2D; GI difference ≥20 units | 12 | −0.15 (−0.35, 0.04) SMD |
| Zafar et al., 2019 ( | NGT; GI difference ≥20 units | 7 | −0.28 (−0.52, −0.04) SMD |
| Zafar et al., 2019 ( | IGT; GI difference ≥20 units | 4 | 0.17 (−0.24, 0.58) SMD |
| Body fat percentage | |||
| Zafar et al., 2019 ( | NGT, IGT, T2D | 21 | 0.00 (−0.14, 0.13) SMD |
| Zafar et al., 2019 ( | NGT | 17 | −0.10 (−0.21, 0.01) SMD |
| Zafar et al., 2019 ( | IGT | 5 | −0.06 (−0.38, 0.26) SMD |
| Fat-free mass (kg) | |||
| Thomas et al., 2007 ( | Overweight, obese | 2 | −0.13 (−0.03, 0.56) kg |
| Schwingshackl et al., 2013 ( | Overweight, obese | 3 | −1.04 (−1.73, −0.35) kg |
| Waist circumference (cm) | |||
| Schwingshackl et al., 2013 ( | Overweight, obese, T2D | 10 | 0.06 (−0.83, 0.96) kg |
CVD, cardiovascular disease; GI, glycemic index; IGT, impaired glucose tolerance; NGT, normal glucose tolerance; RCT, randomized controlled trial; SMD, standardized mean difference; T1D, type 1 diabetes; T2D, type 2 diabetes.